Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-16-024227
Filing Date
2016-06-28
Accepted
2016-06-29 09:43:18
Documents
1
Effectiveness Date
2016-06-28

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-16-024227.paper CERTNAS 294
  Complete submission text file 9999999997-16-024227.txt   1374
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-37722 | Film No.: 16004764
SIC: 2834 Pharmaceutical Preparations